Wiley - Fragment-based Drug Discovery: Lessons And Outlook (2016 EN)

Discussion in 'Chemistry' started by Kanka, Jan 13, 2018.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Likes Received:
    Trophy Points:

    Author: Daniel A. Erlanson (Editor), Wolfgang Jahnke (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)
    Full Title: Fragment-based Drug Discovery: Lessons And Outlook
    Publisher: Wiley-VCH; 1 edition (February 23, 2016)
    Year: 2016
    ISBN-13: 9783527337750 (978-3-527-33775-0), 9783527683628 (978-3-527-68362-8)
    ISBN-10: 352733775X, 3527683623
    Pages: 528
    Language: English
    Genre: Chemistry: Medicinal Chemistry > Drug Discovery & Development
    File type: PDF (True)
    Quality: 10/10
    Price: 144.00 €

    From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding results where other methods have failed. Written by the pioneers in the field, this book provides a comprehensive overview of current methods and applications of fragment-based discovery, as well as an outlook on where the field is headed.

    The first part discusses basic considerations of when to use fragment-based methods, how to select targets, and how to build libraries in the chemical fragment space. The second part describes established, novel and emerging methods for fragment screening, including empirical as well as computational approaches. Special cases of fragment-based screening, e. g. for complex target systems and for covalent inhibitors are also discussed. The third part presents several case studies from recent and on-going drug discovery projects for a variety of target classes, from kinases and phosphatases to targeting protein-protein interaction and epigenetic targets.

    Last edited by a moderator: Sep 14, 2018

Share This Page